Immutep Receives EUR 1.36 Million French R&D Tax Incentive

PUBT · 3d ago
Immutep Receives EUR 1.36 Million French R&D Tax Incentive
  • Immutep received EUR 1.36 million (approximately AUD 2.16 million) under France's R&D tax incentive for eligible 2025 research.
  • The non-dilutive funding will support current R&D on product candidates eftilagimod alfa and IMP761.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immutep Ltd. published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.